Cancer BiologyCancer ResearchPeer-reviewed
VGLL1 drives therapy resistance in estrogen receptor positive breast cancer
C. Gemma, C. Lai, A. Singh…·S. Ali
This study identifies VGLL1 as a driver of resistance to endocrine therapy in ER+ breast cancer and shows that targeting VGLL1/TEAD interaction can inhibit resistant cell growth.
DOI 10.1158/0008-5472.can-24-0013